These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 24904738)
21. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine. Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654 [TBL] [Abstract][Full Text] [Related]
22. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. Ding L; Cao J; Lin W; Chen H; Xiong X; Ao H; Yu M; Lin J; Cui Q Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183020 [TBL] [Abstract][Full Text] [Related]
23. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells. Hu X; Washington S; Verderame MF; Manni A Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252 [TBL] [Abstract][Full Text] [Related]
24. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase. Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328 [TBL] [Abstract][Full Text] [Related]
25. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Benaud CM; Dickson RB Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151 [TBL] [Abstract][Full Text] [Related]
26. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
28. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction. Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572 [TBL] [Abstract][Full Text] [Related]
29. BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma. Hsu JH; Lawlor ER Oncogene; 2011 Apr; 30(17):2077-85. PubMed ID: 21170084 [TBL] [Abstract][Full Text] [Related]
30. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Roskoski R Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305 [TBL] [Abstract][Full Text] [Related]
31. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Poon RY; Toyoshima H; Hunter T Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916 [TBL] [Abstract][Full Text] [Related]
32. Current concepts in neuro-oncology: the cell cycle--a review. Dirks PB; Rutka JT Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259 [TBL] [Abstract][Full Text] [Related]
33. Focal adhesion kinase antisense oligodeoxynucleotides inhibit human pulmonary artery smooth muscle cells proliferation and promote human pulmonary artery smooth muscle cells apoptosis. Lin CL; Zhang ZX; Xu YJ; Ni W; Chen SX Chin Med J (Engl); 2005 Jan; 118(1):20-6. PubMed ID: 15642221 [TBL] [Abstract][Full Text] [Related]
36. Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation. Bond M; Sala-Newby GB; Newby AC J Biol Chem; 2004 Sep; 279(36):37304-10. PubMed ID: 15208331 [TBL] [Abstract][Full Text] [Related]
37. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. Kim NG; Gumbiner BM J Cell Biol; 2015 Aug; 210(3):503-15. PubMed ID: 26216901 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of Drosophila Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation. Roesley SNA; La Marca JE; Deans AJ; Mckenzie L; Suryadinata R; Burke P; Portela M; Wang H; Bernard O; Sarcevic B; Richardson HE Cell Cycle; 2018; 17(13):1559-1578. PubMed ID: 29963966 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials. DePinto W; Chu XJ; Yin X; Smith M; Packman K; Goelzer P; Lovey A; Chen Y; Qian H; Hamid R; Xiang Q; Tovar C; Blain R; Nevins T; Higgins B; Luistro L; Kolinsky K; Felix B; Hussain S; Heimbrook D Mol Cancer Ther; 2006 Nov; 5(11):2644-58. PubMed ID: 17121911 [TBL] [Abstract][Full Text] [Related]
40. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Santamaria D; Ortega S Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]